Myriad Genetics (MYGN)
(Real Time Quote from BATS)
$24.95 USD
-0.52 (-2.04%)
Updated May 13, 2024 03:46 PM ET
4-Sell of 5 4
D Value C Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | 0.00 |
EPS Last Quarter | -0.01 |
Last EPS Surprise | 90.91% |
ABR | 2.45 |
Earnings ESP
|
-100.00% |
---|---|
Current Year | 0.02 |
Next Year | 0.28 |
EPS (TTM) | -0.08 |
P/E (F1) | 1,048.77 |
% EPS Growth Estimates | MYGN | IND | S&P |
---|---|---|---|
Current Qtr (06/2024) | 100.00 | 5,941.58 | 8.49 |
Next Qtr (09/2024) | 200.00 | 161.80 | 11.23 |
Current Year (12/2024) | 107.41 | 12.90 | 15.67 |
Next Year (12/2025) | 1,300.00 | 8.50 | 9.31 |
Past 5 Years | -191.50 | 1.00 | 8.10 |
Next 5 Years | NA | 20.10 | NA |
PE | 1,048.77 | -3.80 | 21.14 |
PEG Ratio | NA | -0.19 | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 205.27M | 209.04M | 831.01M | 898.61M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 207.44M | 211.60M | 836.70M | 912.20M |
Low Estimate | 203.81M | 206.50M | 824.35M | 889.68M |
Year ago Sales | 183.50M | 191.90M | 753.20M | 831.01M |
Year over Year Growth Est. | 11.86% | 8.93% | 10.33% | 8.13% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.00 | 0.03 | 0.02 | 0.28 |
# of Estimates | 6 | 5 | 7 | 7 |
Most Recent Consensus | 0.02 | 0.02 | 0.03 | 0.29 |
High Estimate | 0.02 | 0.06 | 0.04 | 0.37 |
Low Estimate | -0.01 | 0.01 | 0.02 | 0.20 |
Year ago EPS | -0.08 | -0.03 | -0.27 | 0.02 |
Year over Year Growth Est. | 100.00% | 200.00% | 107.41% | 1,257.12% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 0 | 0 | 0 | 2 |
Down Last 60 Days | 0 | 0 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.00 | 0.03 | 0.02 | 0.28 |
7 Days Ago | 0.00 | 0.03 | 0.02 | 0.29 |
30 Days Ago | 0.00 | 0.03 | 0.02 | 0.30 |
60 Days Ago | 0.00 | 0.03 | 0.02 | 0.30 |
90 Days Ago | 0.01 | 0.00 | 0.02 | 0.30 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.00 | 0.03 | 0.02 | 0.26 |
Zacks Consensus Estimate | 0.00 | 0.03 | 0.02 | 0.28 |
Earnings ESP | -100.00% | 0.00% | 0.00% | -7.51% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.01 | 0.04 | -0.03 | -0.08 | NA |
Estimate | -0.11 | 0.02 | -0.08 | -0.10 | NA |
Difference | 0.10 | 0.02 | 0.05 | 0.02 | 0.05 |
Surprise | 90.91% | 100.00% | 62.50% | 20.00% | 68.35% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more